Put to the test
Personalized heart muscle cells made from stem cells in the laboratory could be used to check an individual’s response to potential new drugs before clinical trials.
Main Authors: | Marites T Woon, Timothy J Kamp |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2017-01-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/24276 |
Similar Items
-
Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells
by: Francesca Stillitano, et al.
Published: (2017-01-01) -
Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
by: Agapios Sachinidis
Published: (2020-04-01) -
Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer Drugs
by: Panagiota Papazoglou, et al.
Published: (2021-04-01) -
Cardiotoxicity assessment using 3D vascularized cardiac tissue consisting of human iPSC-derived cardiomyocytes and fibroblasts
by: Kiyoshi Tadano, et al.
Published: (2021-09-01) -
Human Pluripotent Stem Cells for Modeling of Anticancer Therapy-Induced Cardiotoxicity and Cardioprotective Drug Discovery
by: Wendy Keung, et al.
Published: (2021-04-01)